Evidence map›Paper›PMID 31149634›Full record

ArticleScience advances2019

Defining early SIV replication and dissemination dynamics following vaginal transmission.

Claire Deleage, Taina T Immonen, Christine M Fennessey, Arnold Reynaldi, Carolyn Reid, Laura Newman, Leslie Lipkey, Timothy E Schlub, Celine Camus, Sean O'Brien and 7 more

Abstract read
In one paragraph

Article in Science advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Claire DeleageAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID 0000-0002-3507-0055
Taina T ImmonenAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID 0000-0003-4521-0696
Christine M FennesseyAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID 0000-0002-8736-8523
Arnold ReynaldiInfection Analytics Program, Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, Australia.
Carolyn ReidAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Laura NewmanAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID 0000-0002-2693-0754
Leslie LipkeyAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID 0000-0003-0370-7696
Timothy E SchlubThe University of Sydney, Faculty of Medicine and Health, Sydney School of Public Health, New South Wales, Australia.ORCID 0000-0001-7746-9649
Celine CamusAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Sean O'BrienAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID 0000-0002-7168-2489
Jeremy SmedleyLaboratory Animal Sciences Program, Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID 0000-0003-3369-4662
Jessica M ConwayDepartment of Mathematics and Center for Infectious Disease Dynamics, Pennsylvania State University, State College, PA, USA.
Gregory Q Del PreteAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID 0000-0001-6180-5361
Miles P DavenportInfection Analytics Program, Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, Australia.
Jeffrey D LifsonAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID 0000-0002-9494-0268
Jacob D EstesAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Brandon F KeeleAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID 0000-0002-2381-1151

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Viral Testing CoreU42OD010426 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Gregory A Dissen · 2013 to 2026
$6.0M
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENIH HHS P51 OD011092NIH HHS U42 OD010426
6 · The paper itself

Abstract

Understanding HIV transmission is critical to guide the development of prophylactic interventions to prevent infection. We used a nonhuman primate (NHP) model with a synthetic swarm of sequence-tagged variants of SIVmac239 ("SIVmac239X") and scheduled necropsy during primary infection (days 3 to 14 after challenge) to study viral dynamics and host responses to the establishment and dissemination of infection following vaginal challenge. We demonstrate that local replication was initiated at multiple sites within the female genital tract (FGT), with each site having multiple viral variants. Local replication and spread in the FGT preceded lymphatic dissemination. Innate viral restriction factors were observed but appeared to follow viral replication and were ineffective at blocking initial viral establishment and dissemination. However, major delays were observed in time to dissemination in animals and among different viral variants within the same animal. It will be important to assess how phenotypic differences affect early viral dynamics.

Indexed as

AnimalsCD4-Positive T-LymphocytesFemaleGenitalia, FemaleMacaca mulattaSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusTime FactorsVaginaViral LoadVirus Replication

Identifiers

PMID31149634
PMCPMC6541462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.